Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany—A Brief Narrative Review
Open Access
- 28 January 2021
- journal article
- editorial
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 7 (1), 7
- https://doi.org/10.3390/ijns7010007
Abstract
Sickle cell disease (SCD) is a severe non-malignant disorder of hemoglobin and is inherited in an autosomal-recessive mannerKeywords
This publication has 9 references indexed in Scilit:
- Sickle cell disease in Germany: Results from a national registryPediatric Blood & Cancer, 2019
- Newborn screening for sickle cell disease in Europe: recommendations from a Pan‐European Consensus ConferenceBritish Journal of Haematology, 2018
- Sichelzellkrankheit unter Neugeborenen in Deutschland: Eine Studie an Routinedaten der AOKDas Gesundheitswesen, 2018
- Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newbornsAnnals of Hematology, 2018
- The epidemiology of sickle cell disease in Germany following recent large-scale immigrationPediatric Blood & Cancer, 2017
- Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screeningAnnals of Hematology, 2015
- The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area)Pediatric Blood & Cancer, 2015
- Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, GermanyEuropean Journal of Human Genetics, 2014
- Newborn Screening for Sickle Cell Disease: Technical and Legal Aspects of a German Pilot Study with 38,220 ParticipantsBioMed Research International, 2014